A review of the anaesthetic management of children with congenital myotonic dystrophy anaesthetised at the Royal Children 's Hospital over the past ten years is presented. Seven children underwent a total of fourteen anaesthetics. Anaesthetic considerations must include the degree of muscle weakness and hypotonia altering muscle relaxant requirements, aspiration risk due to palatopharyngeal dysfunction, and cardiomyopathy. Succinylcholine caused muscle contracture in a patient without clinical myotonia. This drug should be avoided. Although a low threshold to institute postoperative respiratory support must exist when treating neonates and infants, the older children did not clinically exhibit increased sensitivity to respiratory depressant drugs.
disease onset is in later childhood or early adult life. 5 O'Brien and Harper 5 report a prevalence of one per 100,000 in South Glamorgan (Wales). We report thirteen patients. At the time of study two had died in infancy and one at eighteen years. The Royal Children's Hospital is a major centre of referral for a total population of approximately four million. The prevalence in this community is one per 400,000. Most of the patients O'Brien and Harper report are aged below eighteen years. There is none older than thirty years. Most patients older than eighteen years have swallowing difficulties and aspiration pneumonia is a serious potential complication. Severe muscular disability, mental retardation and decreased fertility imply a poor prognosis for work and normal family life.
Surgery in these children is related to correction of talipes equinovarus (present in 50%), myringotomy (related to disordered swallowing and palatal musculature), and inguinal hernia repair (a result of disordered skeletal muscle). Despite these common presentations for surgery and despite the recognised problems of anaesthesia in adult myotonic dystrophy, anaesthesia in these children is rarely described in the literature.
This paper reviews the experience of fourteen anaesthetics given to seven patients at the Royal Children's Hospital during the past ten years and includes comments on a case concurrently presented. 6 
REVIEW OF LOCAL EXPERIENCE
Literature concerning anaesthesia in children with congenital myotonic dystrophy is scarce. Bray and Inskter 7 describe anaesthetic procedures in two premature neonates. Alexander et al. 8 report the use of caudal anaesthesia for repair of talipes equinovarus deformities in a two-year-old girl. This scarcity prompted review of the anaesthetics given at the Royal Children's Hospital to children with this disease over the past ten years.
Thirteen patients have been diagnosed with this problem. One medical history was unobtainable. Of the remaining twelve patients, seven had a total of fourteen anaesthetics. The age at operation ranged from four months to eleven years. There were four males and three females. The operations are listed in Table 1 .
Anaesthetic drugs and dosages used are presented in Table 2 . It is notable that full doses of anaesthetic agents were usually used. Only one patient, a four-month-old infant, was given a greatly reduced dose of muscle relaxant. This infant was born at 28 weeks' gestation, had been ventilated for the first six weeks of life and was described as 'very floppy' prior to anaesthesia. He was ventilated postoperatively. Most children were ventilated peroperatively. Spontaneous breathing was used for 10-20 minute anaesthetics using halothane (three anaesthetics) or enflurane (one anaesthetic).
Recovery from anaesthesia was uneventful in all but two patients. One, as mentioned,was electively ventilated. Another, an eleven-y.earold boy, was observed overnight in. the Intensive Care Unit. Following a one and a half hour plastic surgical procedure for bat ears in which he was administered 0.4 mg/kg of atracurium (no anticholinesterase given), oxygen saturations of 90% were recorded while breathing spontaneously with supplemental oxygen (Hudson mask, 4 litres 02/minute) in the recovery room. His oxygen saturation rapidly improved over the subsequent hour and he encountered no further respiratory embarrassment.
DISCUSSION
The features of congenital myotonic dystrophy vary with age. The neonate is floppy with proximal muscle weakness but Respiratory muscle weakness in the neonate can be profound, requiring intubation at birth. Although disease expression is variable, non depolarising muscle relaxants should be given in greatly reduced doses. In our experience a premature infant (born at 28 weeks' gestation) only required a 1110 normal dose of tubocurarine at four months of life. Bray? noted 0.2 mg tubocurarine produced good muscle relaxation lasting one hour and ten minutes in a 1.27 kg, 30-week gestation neonate. Sarnat9 speculates that muscle weakness is due to trophic unresponsiveness of abnormal sarcolemma in the presence of essentially normal motor innervation. A central component to respiratory depression is also possible. Facilities should be available for postoperative ventilation in these 'floppy' infants and neonates. Newer shorter-acting relaxants such as vecuronium and atracurium do not guarantee adequate postoperative respiratory function.
In the older child muscle relaxant requirements change. Power and tone have improved. Our patient reported concurrently6 demonstrated evidence of muscle fatigue and weakness. Her cough was poor. She tired easily with exercise. Depolarising relaxants can induce generalised contractures and ventilatory embarrassment in myotonic patients. II This patient had no clinical evidence of myotonia. However, a small dose of succinylcholine (0.5 mg/kg) caused muscle contracture suggesting that it is probably better to avoid this drug even though intubation may be easy when the child eventually relaxes. No other patient in our series received succinylcholine, nor are there any reports of the effects of succinylcholine in patients without clinical myotonia in the literature. In this patient half the normal dose of alcuronium achieved good clinical blockade, but it is uncertain whether the effect on the neuromuscular junction was modified by the prior administration of succinylcholine. Recovery was normal.
Experience at the Royal Children's Hospital suggests normal responses to nondepolarising muscle relaxants. This is consistent with experience in patients with the adult form of the disease. 10 Clinical problems in adult myotonic dystrophy include predominantly distal muscle wasting and weakness along with increased fatiguability and weakness of the diaphragm. II This pathology may affect muscle relaxant use. Prolonged blockade has been described and it is sensible to reduce dosages of nondepolarising relaxants in the presence of dystrophic changes.
Aspiration is a major factor contributing to mortality in all age groupS.5 Swallowing and sucking mechanisms are disordered in the neonate. Delayed gastric emptying and slow peristalsis have been reported. 13 Palatal and pharyngeal muscle weakness persists through childhood. Abnormalities of pharyngooesophageal junction have been demonstrated in adults who have no history of swallowing dysfunction. 14 Some safeguards should be taken against this perioperative hazard. Muscle relaxation should be monitored and full recovery achieved before leaving the operating room. There is a risk of silent aspiration when spontaneous ventilation with a mask is used. Agents causing a significant decrease in conscious state postoperatively should be avoided. Prophylactic antacids or H2 receptor antagonists should be considered, although none of our patients received them.
Myocardial involvement occurs in the adult form of the disease. These are nonspecific cardiomyopathic changes and conduction disturbances. 15 Sarnat l3 reported inconsistent ECG findings in neonates, but cardiomyopathy characterised by vacuolated cardiac muscle fibres was seen at autopsy. One six-year-old patient 6 demonstrated a PR interval of 0.2 sec (normal 0.12-0.16 sec). Consideration must be given to the myocardial depressant effects of potent inhalational agents when anaesthetising these children. Six of the anaesthetics in our series included these agents. Five involved halothane and one enflurane. Although no ill effects were noted, these patients should be monitored perioperatively with ECG precordial leads. Enflurane has been reported AnaeSlhesia and Inlensive Care, Vol. 17, No. 3, AuguSI. 1989 to cause cardiac decompensation in a patient with myotonia dystrophica. 16 Respiratory depressants such as barbiturates,17 narcotics, benzodiazepines and inhalational agents l8 have been reported to cause prolonged apnoea and respiratory depression in adult myotonic dystrophy. In patients with little respiratory reserve due to muscle wasting, diaphragmatic fatigue, increased extrapulmonary impedance due to end-expiration myotonia, and increased PaC02, this is possible. Certainly in the hypotonic neonate, respiratory depression is a real danger. Papaveretum and hyoscine were commonly used in our series with no ill effect.
Thiopentone was the most commonly used induction agent. Exercise levels in these children suggested they did not have borderline respiratory reserve and so were not compromised by these agents.
It is usual in our practice to reverse neuromuscular blockade with neostigmine. In the adult form of the disease neostigmine administration can have a variable response. The patient may have a normal response, neuromuscular blockade can be increased, or a tonic response may ensue. 19 Neostigmine in full dosage was used in six of the anaesthetics in our series with no ill effect. One patient, a two-year-old weighing 11.6 kg, presenting for talipes equinovarus corrective surgery, received half this dose. Muscle relaxation had been achieved with tubocurarine 0.5 mg/kg and forty-five minutes had elapsed since administration of competitive blockade. Two other patients had been given short-acting muscle relaxants and the degree of neuromuscular blockade monitored with an electromyogram. Reversal had not been deemed necessary. It is easy to speculate that if there is no clinical evidence of myotonia then a tonic reaction is unlikely with neostigmine in children with congenital myotonic dystrophy. However, one patient 6 exhibited a marked tonic reaction to succinylcholine even though she had no clinical myotonia. Mechanical ventilation to treat residual paralysis has been advocated as the safest course of action. 18 In conclusion, congenital myotonic dystrophy is a disease process with changing Anaesthesia and Intensive Care. Vol. 17. No. 3, August, 1989 clinical symptoms and signs as the child grows. The gene transmitting the disease has variable expressi vi ty. Anaesthetic considerations must be tailored to the individual patient. These revolve around the following -degree of respiratory muscle weakness, aspiration risks, presence of cardiomyopathy, muscle relaxant use and myotonic contractures (particularly with succinylcholine ).
